Published Date: 08 Mar 2023
Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.
Read Full NewsGenetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease
Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation
Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer
Dolutegravir is already approved as combination therapy in adults and older children
Disease has a continuum of severity, perinatal psychiatrist explains
Nearly one-third of women ages 21 to 29 had never undergone screening
Lifelong pelvic floor issues, such as incontinence, often ensue
1.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer
4.
Acupuncture may alleviate nocturia in men treated for prostate cancer
5.
Analysis of projected cancer rates in Canada by 2024.
1.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
2.
Red Cell Deformability as a Target in Critical Illness
3.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
4.
Innovative Practices in Hematology in the Digital Era
5.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation